Department of Pharmacy Practice

Martin J. Ohlinger, Pharm.D., BCCCP, FCCM

Photo of Dr. Ohlinger

Clinical Associate Professor of Pharmacy Practice
Department of Pharmacy Practice

419.383.1535
Frederic and Mary Wolfe Center 137F
martin.ohlinger@utoledo.edu

Education

  • Critical Care and Emergency Medicine Specialty Residency Detroit Receiving Hospital/University Health Center
  • Doctor of Pharmacy, Virginia Commonwealth University/Medical College of Virginia
  • Bachelor of Science in Pharmacy, Virginia Commonwealth University/Medical College of Virginia
  • Bachelor of Science in Biology, College of William and Mary in Virginia

Scope of Practice and Curriculum

Critical Care (Surgical & Trauma)

Professional Experience

  • Clinical Associate Professor of Pharmacy Practice, The University of Toledo College of Pharmacy and Pharmaceutical Sciences, Toledo, OH
  • Residency Program Director, PGY2 Critical Care Pharmacy Residency, The University of Toledo College of Pharmacy and Pharmaceutical Sciences and Medical Center
  • Clinical Pharmacy Specialist, Surgical Critical Care, University of Toledo Medical Center, Toledo, OH

Recent Publications

Books

  1. Barletta JF, Cooper B, Ohlinger MJ. “Drug Induced Coagulation Disorders”. Chapter 18: Drug Induced Coagulation Disorders, in Drug Induced Complications in the Critically Ill Patient: A Guide for Recognition and Treatment. Editor, Papadopoulos J et al. Society of Critical Care Medicine, 2012.
  2. “The Injectable Drug Reference”, Second Edition, Bioscientific Resources. Editor, Martin SJ. Society of Critical Care Medicine, 2006. Ohlinger MJ – contributing author.
  3. Martin SJ, Ohlinger MJ. “Nosocomial Gram-Negative Infections” in PSAP: Pharmacotherapy Self-Assessment Program. Fifth Edition. American College of Clinical Pharmacy, Kansas City, MO. Copyright 2005
  4. Ohlinger MJ. Management of Healthcare Acquired Pneumonia and Ventilator Associated Pneumonia. Critical Care Self-Assessment Program. American College of Clinical Pharmacy, Kansas City, MO. Copyright 2016.

Abstracts

  1. Amer M, Buschor K, Cole K, Ohlinger MJ.  Identification and management of early sepsis at an academic medical center: Who does is better? Presentation at the Ohio Pharmacy Residency Conference, Ohio Northern University, May 2017.
  2. Outcomes from an Integrated IPE Course across Multiple Healthcare Professions. Sexton M, Masterson M, Metz AE, Ohlinger MJ, Peeters MJ. Collaborating Across Borders V 2015 Conference. Roanoke, VA.
  3. Witt B, Jung R, Ohlinger, MJ.  Efficacy and safety of levetiracetam for seizure prophylaxis in traumatic brain injury.  Presentation at the Ohio Pharmacy Residency Conference, Ohio Northern University, May 2015.
  4. Reale M, Buschor K, Ohlinger, MJ.  Treatment of post-anoxic encephalopathy beyond 48 hours: impact on outcomes and cost.  Presentation at the Ohio Pharmacy Residency Conference, Ohio Northern University, May 2015.
  5. Bassil EH, Peeters MJ, Ohlinger MJ, Zitko KL, Schmude KA, Schneiderman JW, Chen Y. Using simulation for instruction of rapid-sequence intubation and reinforcing basic life support among third-year PharmD students. Pharmacotherapy. 2015; 35(5):e68.
  6. Sanuth B, Jung R, Ohlinger MJ.  Prospective Comparison of Daytime vs. Nighttime Sedatives and Opioid Analgesics Use in the Medical and Surgical Intensive Care Units.  Crit Care Med. 2009;37(12 suppl):A493.  Poster Presentation at 2010 Society of Critical Care Medicine Annual Congress in Miami, FL.

Peer-Reviewed Articles

  1. Barletta JF, Cooper B, Ohlinger MJ. Adverse drug events associated with disorders of coagulation. Crit Care Med 2010;38 (Suppl.):S198-S218.
  2. Dotson BD, Ohlinger MJ. Letter to the editor re: Empiric antimicrobial therapy for healthcare and ventilator associated pneumonia. Crit Care Med 2008;36(5):1696-7.
  3. Sawyer E, Mauro LS, Ohlinger MJ. Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother 2008;42:247-52.

Selected Presentations

  • Shock in Atrial Fibrillation: Which Pharmacologic Agent Should I Use?  Society of Critical Care Medicine Annual Congress. January 2017.  Honolulu, HI.
  • Utilizing Honors Students and Residents in Scholarly Activity.  International Exchange Program, University of Szeged Faculty of Pharmacy. April 2015. Szeged, Hungary.
  • Phi Eta Sigma National Honor Society Spring Induction Ceremony, April 2015. Keynote Speaker.  University of Toledo, Toledo, OH.

Awards

  • Fellow, American College of Critical Care Medicine (2013)
  • Society of Critical Care Medicine Presidential Citation (2003, 2004, 2008, 2011, and 2013)
  • Southeastern Michigan Society of Hospital Pharmacists Resident of the Year (1996)
  • Rho Chi Honor Society (1995)
  • Phi Kappa Phi Honor Society - inducted 2015
  • Board Certified Critical Care Pharmacist (BCCP) - 2016
  • Exemplary Preceptor Award, University of Toledo College of Pharmacy and Pharmaceutical Sciences - 2015, 2016
  • Society of Critical Care Medicine Presidential Citation - 2003, 2004, 2008, 2011, 2013, 2016, and 2017

Leadership 

  • College of Pharmacy and Pharmaceutical Sciences Honors Director
  • PGY2 Critical Care Pharmacy Residency, Program Director
  • College of Pharmacy Admissions Committee, Co-Chair
  • UT Faculty Senate
Last Updated: 8/7/17